Valeant Plans New Sales Strategy For Cesamet; Ends Deal With Par
The two parties have terminated a marketing agreement for the anti-emetic based on a change in strategic priorities.
The two parties have terminated a marketing agreement for the anti-emetic based on a change in strategic priorities.